Literature DB >> 21785859

Amino acids exhibit anti-inflammatory effects in human monocytic leukemia cell line, THP-1 cells.

Shunji Hasegawa1, Takashi Ichiyama, Ichiro Sonaka, Ayami Ohsaki, Reiji Hirano, Yasuhiro Haneda, Reiji Fukano, Masami Hara, Susumu Furukawa.   

Abstract

OBJECTIVE: The elemental diet is one of the effective therapies for inflammatory bowel disease. However, the mechanism remains unclear, and there have never been reports about the inhibitory effects of amino acids in human monocytes/macrophages. We investigated the inhibitory effects of amino acids on cytokine production or expression of adhesion molecules that are involved in inflammatory diseases, in human monocytes/macrophages.
METHODS: We examined the inhibitory effects of cysteine, histidine or glycine on the induction of nuclear factor-κB (NF-κB) activation, expression of intracellular adhesion molecule-1 (ICAM-1, CD54) and production of interleukin-8 (IL-8) in THP-1 cells, a human monocytic leukemia cell line, and peripheral blood mononuclear cells (PBMCs) stimulated with tumor necrosis factor-α (TNF-α).
RESULTS: Cysteine, histidine and glycine significantly reduced the activation of NF-κB in THP-1 cells stimulated with TNF-α. In addition, cysteine and histidine significantly inhibited the expression of ICAM-1 and production of IL-8 in THP-1 cells and PBMCs.
CONCLUSIONS: Our results suggest that cysteine and histidine exhibit anti-inflammatory effects in THP-1 cells, and may be responsible for the efficacy of treatment in inflammatory bowel diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785859     DOI: 10.1007/s00011-011-0362-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  45 in total

1.  Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.

Authors:  G D'haens; S Van Deventer; R Van Hogezand; D Chalmers; C Kothe; F Baert; T Braakman; T Schaible; K Geboes; P Rutgeerts
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

Review 2.  Inflammatory bowel disease: cause and immunobiology.

Authors:  Daniel C Baumgart; Simon R Carding
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

3.  Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity.

Authors:  A Ueda; Y Ishigatsubo; T Okubo; T Yoshimura
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

4.  Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines.

Authors:  N Mukaida; Y Mahe; K Matsushima
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

Review 5.  Glycine: a new anti-inflammatory immunonutrient.

Authors:  M D Wheeler; K Ikejema; N Enomoto; R F Stacklewitz; V Seabra; Z Zhong; M Yin; P Schemmer; M L Rose; I Rusyn; B Bradford; R G Thurman
Journal:  Cell Mol Life Sci       Date:  1999-11-30       Impact factor: 9.261

Review 6.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

7.  Variations in the human Th2-specific chemokine TARC gene.

Authors:  Takashi Sekiya; Yuichiro Tsunemi; Misato Miyamasu; Ken Ohta; Atsushi Morita; Hidehisa Saeki; Kouji Matsushima; Osamu Yoshie; Naoyuki Tsuchiya; Masao Yamaguchi; Kazuhiko Yamamoto; Kunihiko Tamaki; Koichi Hirai
Journal:  Immunogenetics       Date:  2003-01-09       Impact factor: 2.846

8.  Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages.

Authors:  Ayatoshi Andou; Tadakazu Hisamatsu; Susumu Okamoto; Hiroshi Chinen; Nobuhiko Kamada; Taku Kobayashi; Masaki Hashimoto; Tomohisa Okutsu; Kazutaka Shimbo; Tomoko Takeda; Hideki Matsumoto; Atsushi Sato; Hiroshi Ohtsu; Manabu Suzuki; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2008-10-07       Impact factor: 22.682

9.  Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation.

Authors:  C C Chen; C L Rosenbloom; D C Anderson; A M Manning
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

10.  An immunoglobulin agent (IVIG) inhibits NF-kappaB activation in cultured endothelial cells of coronary arteries in vitro.

Authors:  T Ichiyama; Y Ueno; H Isumi; A Niimi; T Matsubara; S Furukawa
Journal:  Inflamm Res       Date:  2004-05-12       Impact factor: 4.575

View more
  6 in total

1.  Cysteine, histidine and glycine exhibit anti-inflammatory effects in human coronary arterial endothelial cells.

Authors:  S Hasegawa; T Ichiyama; I Sonaka; A Ohsaki; S Okada; H Wakiguchi; K Kudo; S Kittaka; M Hara; S Furukawa
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

2.  Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in Remission.

Authors:  Tadakazu Hisamatsu; Nobukazu Ono; Akira Imaizumi; Maiko Mori; Hiroaki Suzuki; Michihide Uo; Masaki Hashimoto; Makoto Naganuma; Katsuyoshi Matsuoka; Shinta Mizuno; Mina T Kitazume; Tomoharu Yajima; Haruhiko Ogata; Yasushi Iwao; Toshifumi Hibi; Takanori Kanai
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

Review 3.  Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease.

Authors:  Yulan Liu; Xiuying Wang; Chien-An Andy Hu
Journal:  Nutrients       Date:  2017-08-23       Impact factor: 5.717

4.  Modular systems metabolic engineering enables balancing of relevant pathways for l-histidine production with Corynebacterium glutamicum.

Authors:  Andreas Schwentner; André Feith; Eugenia Münch; Judith Stiefelmaier; Ira Lauer; Lorenzo Favilli; Christoph Massner; Johannes Öhrlein; Bastian Grund; Andrea Hüser; Ralf Takors; Bastian Blombach
Journal:  Biotechnol Biofuels       Date:  2019-03-25       Impact factor: 6.040

Review 5.  Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin.

Authors:  Gian Mario Cortes; Maria Antonietta Marcialis; Flaminia Bardanzellu; Angelica Corrias; Vassilios Fanos; Michele Mussap
Journal:  Front Microbiol       Date:  2022-03-21       Impact factor: 6.064

Review 6.  The Gut-Immune-Brain Axis in Autism Spectrum Disorders; A Focus on Amino Acids.

Authors:  Joris H J van Sadelhoff; Paula Perez Pardo; Jiangbo Wu; Johan Garssen; Jeroen van Bergenhenegouwen; Astrid Hogenkamp; Anita Hartog; Aletta D Kraneveld
Journal:  Front Endocrinol (Lausanne)       Date:  2019-04-16       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.